0.6945
2.02%
0.0138
Co Diagnostics Inc Borsa (CODX) Ultime notizie
CODX INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Co-Diagnostics (CODX) Investors with Significant Losses to Contact the Firm’s Attorneys, Securities Class Action Filed - ACCESS Newswire
Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Resul - GuruFocus.com
Co-Diagnostics, Inc. to Exhibit at BioUtah's 2025 Life Sciences Day on the Hill - WV News
Revolutionary At-Home Disease Testing: Co-Diagnostics Unveils Next-Gen PCR Platform - StockTitan
Co-Diagnostics, Inc.: Live from Silicon Slopes - Nasdaq
CODX FINAL DEADLINE: ROSEN, A LEADING FIRM, Encourages Co-Diagnostics, Inc. Investors to Contact Firm Before Important August 17 Deadline in Securities Class Action Seeking Recovery of Investor LossesCODX - AccessWire
Quest Diagnostics (DGX) Stock Price, News & Analysis - MarketBeat
Jane Street Group LLC Makes New $55,000 Investment in Co-Diagnostics, Inc. (NASDAQ:CODX) - Defense World
CODX (Co-Diagnostics) 5-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
Co-Diagnostics faces potential Nasdaq delisting over share price - Investing.com
Co-Diagnostics faces potential Nasdaq delisting over share price By Investing.com - Investing.com Nigeria
Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025 - PR Newswire
Head to Head Contrast: Co-Diagnostics (NASDAQ:CODX) vs. Vasamed (OTCMKTS:VSMD) - Defense World
Co-Diagnostics (NASDAQ:CODX) and Aethlon Medical (NASDAQ:AEMD) Critical Review - Defense World
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Rele - GuruFocus.com
Financial Review: Co-Diagnostics (NASDAQ:CODX) & Endologix (OTCMKTS:ELGXQ) - Defense World
Co-Diagnostics stock hits 52-week low at $0.79 amid market challenges - Investing.com
CoSara Diagnostics inaugurates new oligo facility in Ranoli, Gujarat - BSI bureau
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility - Marketscreener.com
Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast - The Eastern Progress Online
Make in India: CoSara Diagnostics to open oligo facility in Ranoli - Medical Buyer
Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan - The Eastern Progress Online
Co-Diagnostics stock hits 52-week low at $0.85 amid market challenges - Investing.com Canada
Co-Diagnostics (FRA:C97) Earnings Yield % : N/A% (As of Dec. 05, 2024) - GuruFocus.com
Co-Diagnostics (FRA:C97) Enterprise Value : €-6.97 Mil (As of Dec. 05, 2024) - GuruFocus.com
Co-Diagnostics (STU:C97) Momentum Rank : 7 (As of Dec. 05, 2024) - GuruFocus.com
Co-Diagnostics (FRA:C97) EBITDA per Share : €-1.18 (TTM As of Sep. 2024) - GuruFocus.com
Co-Diagnostics (FRA:C97) 3-Year FCF Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
Co-Diagnostics (HAM:C97) Price-to-Operating-Cash-Flow : (As of Dec. 01, 2024) - GuruFocus.com
Co-Diagnostics (HAM:C97) 50-Day SMA : €1.07 (As of Nov. 30, 2024) - GuruFocus.com
Rabies Diagnostics Market Report Details Trends and Growth Analysis Report 2024 - WhaTech
Co-Diagnostics (HAM:C97) Cash Flow from Operations : €-23.54 Mil (TTM As of Sep. 2024) - GuruFocus.com
Co-Diagnostics (HAM:C97) Forward Rate of Return (Yacktman) % : 0.00% (As of Sep. 2024) - GuruFocus.com
Co-Diagnostics (HAM:C97) Change In Inventory : €0.32 Mil (TTM As of Sep. 2024) - GuruFocus.com
Co-Diagnostics (HAM:C97) Forward Dividend Yield % : 0.00% (As of Nov. 26, 2024) - GuruFocus.com
CODX (Co-Diagnostics) 3-Year Book Growth Rate : 5.60% (As of Sep. 2024) - GuruFocus.com
Co-Diagnostics stock hits 52-week low at $1 amid market challenges - Investing.com Australia
CODX (Co-Diagnostics) Momentum Rank : 8 (As of Nov. 26, 2024) - GuruFocus.com
Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention & Expo on Oct 2-3 - GuruFocus.com
Co-Diagnostics stock hits 52-week low at $1 amid market challenges By Investing.com - Investing.com South Africa
CODX (Co-Diagnostics) 3-Year EPS without NRI Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
Co-Diagnostics (HAM:C97) Cash Flow from Discontinued Operat - GuruFocus.com
Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results - GuruFocus.com
Co-Diagnostics (LTS:0A50) Total Liabilities : $8.60 Mil (As of Sep. 2024) - GuruFocus.com
Daxor (NASDAQ:DXR) & Co-Diagnostics (NASDAQ:CODX) Critical Survey - Defense World
Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Tops Revenue Estimates - MSN
Leading Molecular Diagnostics Company BillionToOne Announces Three Executive Appointments Amid Rapid Growth - PR Newswire
Co-Diagnostics Q3 2024 Earnings Preview - MSN
Co-Diagnostics Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Co-Diagnostics, Inc. (NASDAQ:CODX) Q3 2024 Earnings Call Transcript - Insider Monkey
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):